Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CT/Norwich
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Norwich, CT

Studies commonly pay $75 to $4,500 per completed study

115 clinical trials are currently recruiting participants within 30 miles of Norwich. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

115studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Norwich right now

Top 25 of 115 recruiting studies, sorted by proximity — each links to its official registry page

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Age-related Wet Macular Degeneration Phase 1 Interventional 45 participants sought
CBCC Global Research Site:005 — Manchester, Connecticut (27.3 mi) · Sponsor: Caregen Co. Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06132035)

A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia

Hemiplegia, Cerebral Palsy N/A Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (19.7 mi) · Sponsor: University of Connecticut
See eligibility & contact on ClinicalTrials.gov (NCT06579027)

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Radiation Retinopathy, Visual Impairment Phase 3 Interventional 600 participants sought
Retina Consultants — Manchester, Connecticut (27.3 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT05844982)

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Transthyretin Amyloidosis With Cardiomyopathy Phase 3 Interventional 1,750 participants sought
Clinical Trial Site — Norwich, Connecticut (1.9 mi) · Sponsor: Alnylam Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07052903)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Fibromyalgia Phase 3 Interventional 620 participants sought
Clinical Research Site — Cromwell, Connecticut (29.0 mi) · Sponsor: Axsome Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07398417)

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Retroperitoneal Sarcoma, Liposarcoma Phase 3 Interventional 250 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
See eligibility & contact on ClinicalTrials.gov (NCT04031677)

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

Multiple Myeloma Phase 2 Interventional 200 participants sought
GSK Investigational Site — Norwich, Connecticut (1.9 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT07227311)

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought
Hartford HealthCare - Manchester — Manchester, Connecticut (27.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04871542)

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

Resectable Intrahepatic Cholangiocarcinoma Phase 2 Interventional 27 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06050252)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Eastern CT Hematology & Oncology Associates ( Site 0033) — Norwich, Connecticut (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

Metastatic Colorectal Cancer Phase 1 Interventional 542 participants sought
Eastern Ct Hema/Onco Assoc — Norwich, Connecticut (1.9 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT04929223)

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Plaque Psoriasis Phase 2 Interventional 240 participants sought
Oruka Therapeutics Investigative Site — Cromwell, Connecticut (29.0 mi) · Sponsor: Oruka Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07449702)

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype Phase 2 Interventional 900 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06769126)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Hartford HealthCare - Manchester — Manchester, Connecticut (27.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06498635)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Major Depressive Disorder Phase 3 Interventional 450 participants sought
Ct Clinical Research Associates — Cromwell, Connecticut (29.0 mi) · Sponsor: Xenon Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06775379)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

Macular Degeneration, Age-Related Macular Degeneration Phase 2, Phase 3 Interventional 960 participants sought
Retina Group of New England — Waterford, Connecticut (14.6 mi) · Sponsor: EyeBiotech Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07496567)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) Phase 3 Interventional 975 participants sought
Retina Group of New England — Waterford, Connecticut (14.6 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06541704)

A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.

Periodontitis (Stage 3) N/A Interventional 72 participants sought
Shoreline Periodontics and Dental Implants — New London, Connecticut (13.4 mi) · Sponsor: McGuire Institute
See eligibility & contact on ClinicalTrials.gov (NCT06914596)

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

Gynecologic Cancer, Chemotherapy-induced Peripheral Neuropathy N/A Interventional 190 participants sought
Middlesex Health Cancer Center - Middletown — Middletown, Connecticut (29.1 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06139458)

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Pancreatic Neoplasm N/A Observational 770 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04239573)
Actively enrolling

Studies you may be able to join near Norwich

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Norwich

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Comprehensive Research Center

200 W Town St, Norwich, CT 06360
(860) 886-1508 ext. 23

Eastern Connecticut Hematology and Oncology

★ 4.7 (215 reviews)
Medical Office Building, 330 Washington St STE 220, Norwich, CT 06360
(860) 886-8362
"It was a good visit informational and understood all that was told to me"
— Milton Poppie, 4★

Coastal Connecticut Research

★ 5.0
342 Montauk Ave, New London, CT 06320
(860) 437-7092
"Clinical trials and research studies for multiple sclerosis, alzheimer's, overactive bladder, hot flashes, and birth control, Friendly, caring, kn…"
— Sindi Mannochi, 5★

ECHO Cancer Foundation

★ 5.0
330 Washington St, Norwich, CT 06360
(860) 460-9722

CT Clinical Research

160 West St Ste 1A, Cromwell, CT 06416
(860) 632-0144

Chase Medical Research, LLC

★ 5.0
1952 Whitney Ave, Hamden, CT 06517
(203) 419-4404
"I would like to start by saying that stuff are amazing there. Special thanks to three very professional and cool at the same time ladies Amanda, Sam…"
— Denise Mizla, 5★

Clinical Trials of New England

1234 Hyde Park Ave #205, Hyde Park, MA 02136

Clinical Trials

100 Retreat Ave, Hartford, CT 06106
(860) 244-0148

Clinical Research Consulting LLC

★ 4.0
2080 Bridgeport Ave D, Milford, CT 06460
(203) 386-3115
"Just finishing up a research study with them, they are all very friendly and organized. They are efficient and do a good job of getting you in and ou…"
— Stephen Callahan, 5★

Clinical trials in Norwich: what's recruiting

The Norwich area currently has 115 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Norwich, the most active research areas are:

  • Cancer & Oncology11 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health2 studies
  • Liver & Kidney1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Norwich, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Norwich

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Norwich participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Norwich?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Norwich safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Norwich, CT?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Norwich?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Norwich.

Paid clinical trials near Norwich

Other metros within reach

Hartford, CT437 Providence, RI554 Springfield, MA315 Worcester, MA270 New Haven, CT1,178 Waterbury, CT1,134 New Bedford, MA517 Bridgeport, CT1,449

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Norwich Bladder Issues Due To Spinal Cord Injury in Norwich All conditions

More of CT

Bridgeport1,449 New Haven1,178 Danbury1,160 Waterbury1,134 Hartford437

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts